Medispend Resources
State Price Transparency Reporting: Why It’s No Longer a Peripheral Compliance Task
State Price Transparency Reporting (SPTR) has changed quietly, rapidly, and in ways that materially affect pharmaceutical manufacturers. What was once treated as an occasional filing obligation has evolved into a continuous compliance and operational risk. With more than 20 states actively enforcing drug price transparency requirements and new legislation continuing to emerge, the challenge today
State of Coaching in Pharma 2026 – What’s Working, What’s Not, and What’s Next
Coaching in pharma is no longer a “nice‑to‑have.” In 2026, it is a strategic, auditable, and measurable capability—or a growing operational risk. As pharmaceutical organizations face increasing portfolio complexity, evolving customer engagement models, and heightened regulatory scrutiny, one question is becoming unavoidable: Is your coaching model truly
State of Coaching in Pharma 2026 – What’s Working. What’s Not. And What’s Next.
Coaching has become one of the most critical—and most scrutinized—capabilities in the pharmaceutical industry. As organizations face growing complexity, heightened compliance expectations, and pressure to prove impact, many are discovering that how coaching happens matters more than whether it happens at all. This eBook offers a clear, data‑driven look at
Operationalizing Scientific Exchange: How Medical Affairs Delivers Measurable Impact
Today, Medical Affairs has achieved digitization, but digital alone is no longer enough. To meet rising expectations from regulators, leadership, and global compliance environments, teams must operationalize scientific exchange: embedding governance, consistency, and visibility directly into daily workflows. This eBook explores how purpose‑built technology, connected governance, and AI‑enabled insight capture
State Price Transparency Reporting Solution Checklist
This State Price Transparency Compliance Checklist helps life sciences organizations stay ahead of evolving state reporting requirements. Use it to assess your current readiness, identify compliance gaps, and take a more proactive approach to regulatory monitoring, reporting, and price change planning.
State Drug Price Transparency Reporting: Enforcement Trends, Risk Exposure & Operational Readiness
State Price Transparency Reporting (SPTR) has rapidly evolved from an occasional filing obligation into a core compliance and operational responsibility for pharmaceutical manufacturers. With more than 20 states actively enforcing reporting requirements, and additional legislation emerging, manufacturers face increasing risk tied to missed triggers, inconsistent data, and cross‑functional misalignment. In